BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 24684389)

  • 1. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.
    Fatokun AA; Dawson VL; Dawson TM
    Br J Pharmacol; 2014 Apr; 171(8):2000-16. PubMed ID: 24684389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
    Liu L; Li J; Ke Y; Zeng X; Gao J; Ba X; Wang R
    Cell Mol Life Sci; 2022 Jan; 79(1):60. PubMed ID: 35000037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
    Wang Y; Kim NS; Haince JF; Kang HC; David KK; Andrabi SA; Poirier GG; Dawson VL; Dawson TM
    Sci Signal; 2011 Apr; 4(167):ra20. PubMed ID: 21467298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.
    Wang Y; Dawson VL; Dawson TM
    Exp Neurol; 2009 Aug; 218(2):193-202. PubMed ID: 19332058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos).
    Wang Y; Kim NS; Li X; Greer PA; Koehler RC; Dawson VL; Dawson TM
    J Neurochem; 2009 Jul; 110(2):687-96. PubMed ID: 19457082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.
    Mashimo M; Onishi M; Uno A; Tanimichi A; Nobeyama A; Mori M; Yamada S; Negi S; Bu X; Kato J; Moss J; Sanada N; Kizu R; Fujii T
    J Biol Chem; 2021; 296():100046. PubMed ID: 33168626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
    Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
    Xu X; Sun B; Zhao C
    Neurobiol Dis; 2023 Oct; 187():106314. PubMed ID: 37783233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53.
    So KY; Oh SH
    Biochem Biophys Res Commun; 2023 May; 656():78-85. PubMed ID: 36958258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases.
    Park H; Kam TI; Dawson TM; Dawson VL
    Int Rev Cell Mol Biol; 2020; 353():1-29. PubMed ID: 32381174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling.
    Hong SJ; Dawson TM; Dawson VL
    Trends Pharmacol Sci; 2004 May; 25(5):259-64. PubMed ID: 15120492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) makes a date with death.
    Heeres JT; Hergenrother PJ
    Curr Opin Chem Biol; 2007 Dec; 11(6):644-53. PubMed ID: 17936669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress.
    Mashimo M; Kato J; Moss J
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18964-9. PubMed ID: 24191052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Death Mechanisms of Neurodegeneration.
    Fan J; Dawson TM; Dawson VL
    Adv Neurobiol; 2017; 15():403-425. PubMed ID: 28674991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors.
    Pan YR; Song JY; Fan B; Wang Y; Che L; Zhang SM; Chang YX; He C; Li GY
    Cell Commun Signal; 2020 Feb; 18(1):27. PubMed ID: 32066462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parthanatos, a messenger of death.
    David KK; Andrabi SA; Dawson TM; Dawson VL
    Front Biosci (Landmark Ed); 2009 Jan; 14(3):1116-28. PubMed ID: 19273119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observation of Parthanatos Involvement in Diminished Ovarian Reserve Patients and Melatonin's Protective Function Through Inhibiting ADP-Ribose (PAR) Expression and Preventing AIF Translocation into the Nucleus.
    Batnasan E; Xie S; Zhang Q; Li Y
    Reprod Sci; 2020 Jan; 27(1):75-86. PubMed ID: 32046374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) signaling in cell death.
    VirĂ¡g L; Robaszkiewicz A; Rodriguez-Vargas JM; Oliver FJ
    Mol Aspects Med; 2013 Dec; 34(6):1153-67. PubMed ID: 23416893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
    Zhou Y; Feng X; Koh DW
    Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly (ADP-ribose) in the pathogenesis of Parkinson's disease.
    Lee Y; Kang HC; Lee BD; Lee YI; Kim YP; Shin JH
    BMB Rep; 2014 Aug; 47(8):424-32. PubMed ID: 24874851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.